Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L A, Emens"'
Publikováno v:
Cytotherapy. 7(1)
GM-CSF-secreting, allogeneic cell-based cancer vaccines have shown promise for the treatment of a variety of solid tumors. We have now applied this approach to breast cancer. The aim of these studies was to optimize expansion parameters, qualify the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62fadcfc3c72b4664e953580b5cbcd6a
https://pubmed.ncbi.nlm.nih.gov/16040383
https://pubmed.ncbi.nlm.nih.gov/16040383
Publikováno v:
Current opinion in investigational drugs (London, England : 2000). 2(1)
Recent advances in our understanding of immune function with regard to the generation of a potent antitumor response have resulted in a renewed interest in cancer vaccines and point to a role for immunotherapy in the treatment of cancer. Currently, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d954df45060b436f672cfa8471993e18
https://pubmed.ncbi.nlm.nih.gov/11527005
https://pubmed.ncbi.nlm.nih.gov/11527005
Publikováno v:
Current opinion in molecular therapeutics. 3(1)
Cancer vaccines are on the threshold of taking their place alongside the more traditional cancer treatment modalities of surgery, radiation therapy and chemotherapy. The toxicology and immunopharmacology of therapeutic cancer vaccines, particularly t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a562f86e9011d208649c7320d706e406
https://pubmed.ncbi.nlm.nih.gov/11249735
https://pubmed.ncbi.nlm.nih.gov/11249735
Autor:
R T, Reilly, J P, Machiels, L A, Emens, A M, Ercolini, F I, Okoye, R Y, Lei, D, Weintraub, E M, Jaffee
Publikováno v:
Cancer Research, Vol. 61, no.3, p. 880-883 (2001)
HER-2/neu (neu) transgenic mice (neu-N mice), which express the nontransforming rat proto-oncogene, demonstrate immunological tolerance to neu that is similar to what is encountered in patients with neu-expressing breast cancer. We have shown previou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::64bd24b8fe3c31548ca433cfffe0cdde
https://hdl.handle.net/2078.1/212974
https://hdl.handle.net/2078.1/212974
Autor:
J P, Machiels, R T, Reilly, L A, Emens, A M, Ercolini, R Y, Lei, D, Weintraub, F I, Okoye, E M, Jaffee
Publikováno v:
Cancer Research, Vol. 61, no.9, p. 3689-3697 (2001)
Tumor-specific immune tolerance limits the effectiveness of cancer vaccines. In addition, tumor vaccines alone have a limited potential for the treatment of measurable tumor burdens. This highlights the importance of identifying more potent cancer va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::98f72c893e4434dbe5303bd013cc256f
https://hdl.handle.net/2078.1/212972
https://hdl.handle.net/2078.1/212972